Literature DB >> 7855219

Effects of naloxone on diurnal rhythms in mood and endocrine function: a dose-response study in man.

A F Martin del Campo1, J H Dowson, J Herbert, E S Paykel.   

Abstract

This study investigated diurnal variations in the affective and endocrine response to opioid blockade in man and whether there were effects related either to the dose of naloxone or the time of day at which it was given. Normal male subjects were given an intravenous bolus of either 0.2 mg/kg (study 1) or 1 mg/kg naloxone (study 2) or control infusions at two time points (0900 or 1800 hours) in a single-blind crossover design. Before and following each infusion, mood was measured by the Profile of Mood States (POMS) and a visual analogue scale (VAS), and blood samples taken at 15-min intervals. Cortisol, LH ACTH and vasopressin (study 2 only) were measured. Blood pressure and heart rate were also monitored. The lower dose of naloxone had no effect on overall mood (POMS), though tension and confusion were increased in the afternoon. The VAS showed increased depression in the afternoon, and heightened tension, sleepiness and reduced ability to concentrate at both times of day. The higher dose increased overall dysphoria at both time points, though the tension and depression subscales were not altered. VAS depression and tension were increased, and there were changes in sleepiness. Subjective reports showed that 45% of the subjects correctly identified the drug treatment at the lower dose compared with 89% at the higher one. ACTH increased after both doses of naloxone irrespective of time of day. Cortisol was also raised by naloxone; the effect was greater in the afternoon for the lower dose, but not the higher.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7855219     DOI: 10.1007/bf02244988

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

1.  CORTISOL SECRETION RATE IN DEPRESSIVE ILLNESS.

Authors:  J L GIBBONS
Journal:  Arch Gen Psychiatry       Date:  1964-06

2.  Naloxone increases ACTH and cortisol levels in man.

Authors:  J Volavka; D Cho; A Mallya; J Bauman
Journal:  N Engl J Med       Date:  1979-05-03       Impact factor: 91.245

3.  Neuroendocrine responses of type A individuals to exercise.

Authors:  R G McMurray; C J Hardy; S Roberts; W A Forsythe; M H Mar
Journal:  Behav Med       Date:  1989       Impact factor: 3.104

4.  Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness.

Authors:  F Bloom; D Segal; N Ling; R Guillemin
Journal:  Science       Date:  1976-11-05       Impact factor: 47.728

Review 5.  The neuroendocrinology of opioid peptides.

Authors:  A Grossman; L H Rees
Journal:  Br Med Bull       Date:  1983-01       Impact factor: 4.291

Review 6.  Behavioral effects after systemic injection of opiate peptides.

Authors:  R D Olson; A J Kastin; G A Olson; D H Coy
Journal:  Psychoneuroendocrinology       Date:  1980-01       Impact factor: 4.905

7.  Different opioid mechanisms are involved in the modulation of ACTH and gonadotrophin release in man.

Authors:  A Grossman; P J Moult; D Cunnah; M Besser
Journal:  Neuroendocrinology       Date:  1986       Impact factor: 4.914

8.  Effects of naloxone on experimentally induced ischemic pain and on mood in human subjects.

Authors:  P Grevert; A Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

9.  A unified biosocial theory of personality and its role in the development of anxiety states.

Authors:  C R Cloninger
Journal:  Psychiatr Dev       Date:  1986

10.  24-hour cortisol measures in adolescents with major depression: a controlled study.

Authors:  R E Dahl; N D Ryan; J Puig-Antich; N A Nguyen; M al-Shabbout; V A Meyer; J Perel
Journal:  Biol Psychiatry       Date:  1991-07-01       Impact factor: 13.382

View more
  16 in total

1.  Trait anger and blood pressure recovery following acute pain: evidence for opioid-mediated effects.

Authors:  Stephen Bruehl; Ok Yung Chung; John W Burns
Journal:  Int J Behav Med       Date:  2006

2.  Personality trait predictors of placebo analgesia and neurobiological correlates.

Authors:  Marta Peciña; Hamdan Azhar; Tiffany M Love; Tingting Lu; Barbara L Fredrickson; Christian S Stohler; Jon-Kar Zubieta
Journal:  Neuropsychopharmacology       Date:  2012-11-16       Impact factor: 7.853

Review 3.  Anger expression and pain: an overview of findings and possible mechanisms.

Authors:  Stephen Bruehl; Ok Y Chung; John W Burns
Journal:  J Behav Med       Date:  2006-06-29

Review 4.  Stress and Addiction: When a Robust Stress Response Indicates Resiliency.

Authors:  Mustafa alʼAbsi
Journal:  Psychosom Med       Date:  2018-01       Impact factor: 4.312

Review 5.  Pain-related effects of trait anger expression: neural substrates and the role of endogenous opioid mechanisms.

Authors:  Stephen Bruehl; John W Burns; Ok Y Chung; Melissa Chont
Journal:  Neurosci Biobehav Rev       Date:  2008-12-25       Impact factor: 8.989

6.  Acute HPA axis response to naltrexone differs in female vs. male smokers.

Authors:  Daniel J O Roche; Emma Childs; Alyssa M Epstein; Andrea C King
Journal:  Psychoneuroendocrinology       Date:  2009-10-17       Impact factor: 4.905

7.  Opioid-receptor antagonism increases pain and decreases pleasure in obese and non-obese individuals.

Authors:  Rebecca C Price; Nicolas V Christou; Steven B Backman; Laura Stone; Petra Schweinhardt
Journal:  Psychopharmacology (Berl)       Date:  2016-09-22       Impact factor: 4.530

8.  Blunted opiate modulation of hypothalamic-pituitary-adrenocortical activity in men and women who smoke.

Authors:  Mustafa al'Absi; Lorentz E Wittmers; Dorothy Hatsukami; Ruth Westra
Journal:  Psychosom Med       Date:  2008-09-16       Impact factor: 4.312

9.  Opioid and cocaine combined effect on cocaine-induced changes in HPA and HPG axes hormones in men.

Authors:  Nathalie V Goletiani; Jack H Mendelson; Michelle B Sholar; Arthur J Siegel; Nancy K Mello
Journal:  Pharmacol Biochem Behav       Date:  2008-09-18       Impact factor: 3.533

10.  Blocking central opiate function modulates hedonic impact and anterior cingulate response to rewards and losses.

Authors:  Predrag Petrovic; Burkhard Pleger; Ben Seymour; Stefan Klöppel; Benedetto De Martino; Hugo Critchley; Raymond J Dolan
Journal:  J Neurosci       Date:  2008-10-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.